Literature DB >> 3559978

Biochemical changes in tissue catecholamines and serotonin in duodenal ulceration caused by cysteamine or propionitrile in the rat.

S Szabo, H C Horner, H Maull, J Schnoor, C C Chiueh, M Palkovits.   

Abstract

Previous structure-activity and pharmacologic studies with duodenal ulcerogens cysteamine and propionitrile implicating catecholamines in the pathogenesis of duodenal ulceration have now been followed up by dose- and time-response biochemical investigations to assess the importance of monoamines in the development of duodenal ulcers. The concentrations of norepinephrine (noradrenaline), dopamine, serotonin and their metabolites were measured in total brain, brain regions, stomach, duodenum, pancreas and adrenals in the rat. Turnover of catecholamines was determined in rats pretreated with the inhibitor of tyrosine hydroxylase alpha-methyl-p-tyrosine. The duodenal ulcerogens caused a dose- and time-dependent depletion of norepinephrine in virtually all the tissues examined. The effect was maximal 4 or 7 hr after cysteamine or propionitrile, and norepinephrine levels returned to normal in 24 hr. Dopamine changes were selective and often biphasic, e.g., elevation in adrenals, biphasic in brain cortex, hippocampus and midbrain, but uniformly decreasing in glandular stomach and duodenum. In the median eminence dopamine levels decreased by 181 and 324% at 15 and 30 min, respectively, after cysteamine, but neither dopamine nor 3,4-dihydroxyphenylacetic acid was modified in the periventricular nucleus. Serotonin levels were relatively stable, revealing slight elevations or no changes in most of the tissues. The turnover of norepinephrine was accelerated by both chemicals in virtually all brain regions, but dopamine turnover was affected only in a few areas, e.g., in the corpus striatum and medulla oblongata cysteamine decreased dopamine turnover, whereas propionitrile first (at 1 hr) accelerated then (at 8 hr) significantly suppressed it.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3559978

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  11 in total

1.  Role of Dopamine and D2 Dopamine Receptor in the Pathogenesis of Inflammatory Bowel Disease.

Authors:  Ganna Tolstanova; Xiaoming Deng; Amrita Ahluwalia; Brankica Paunovic; Alona Prysiazhniuk; Lyudmyla Ostapchenko; Andrzej Tarnawski; Zsuzsanna Sandor; Sandor Szabo
Journal:  Dig Dis Sci       Date:  2015-05-14       Impact factor: 3.199

2.  Influence of cysteamine and cysteine on open-field behaviour, and on brain concentrations of catecholamines, somatostatin, neuropeptide Y, and corticotropin releasing hormone in the rat.

Authors:  L Vécsei; R Ekman; C Alling; E Widerlöv
Journal:  J Neural Transm Gen Sect       Date:  1989

Review 3.  Dopamine in gastrointestinal disease.

Authors:  G B Glavin; S Szabo
Journal:  Dig Dis Sci       Date:  1990-09       Impact factor: 3.199

4.  Effects of pregnancy in rats on cysteamine-induced peptic ulcers: role of progesterone.

Authors:  C Montoneri; F Drago
Journal:  Dig Dis Sci       Date:  1997-12       Impact factor: 3.199

5.  Class side effects: decreased pressure in the lower oesophageal and the pyloric sphincters after the administration of dopamine antagonists, neuroleptics, anti-emetics, L-NAME, pentadecapeptide BPC 157 and L-arginine.

Authors:  Zeljka Belosic Halle; Josipa Vlainic; Domagoj Drmic; Dean Strinic; Kresimir Luetic; Mario Sucic; Maria Medvidovic-Grubisic; Tatjana Pavelic Turudic; Igor Petrovic; Sven Seiwerth; Predrag Sikiric
Journal:  Inflammopharmacology       Date:  2017-05-17       Impact factor: 4.473

6.  Phase advances of circadian rhythms in somatostatin depleted rats: effects of cysteamine on rhythms of locomotor activity and electrical discharge of the suprachiasmatic nucleus.

Authors:  C Fukuhara; T Hamada; S Shibata; S Watanabe; K Aoki; S I Inouye
Journal:  J Comp Physiol A       Date:  1994-12       Impact factor: 1.836

7.  Catecholamine concentrations in biopsied gastroduodenal tissue specimens of patients with duodenal ulcer.

Authors:  M Kaise; H Echizen; N Umeda; T Ishizaki
Journal:  Dig Dis Sci       Date:  1993-10       Impact factor: 3.199

8.  Role of iron in the pathogenesis of cysteamine-induced duodenal ulceration in rats.

Authors:  Tetyana Khomenko; Sandor Szabo; Xiaoming Deng; Hideki Ishikawa; Gregory J Anderson; Gordon D McLaren
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2009-04-02       Impact factor: 4.052

9.  Catecholamine-synthesizing enzymes in the rat stomach.

Authors:  N Bäck; M Ahonen; S Soinila; E Kivilaakso; T Kiviluoto
Journal:  Histochem Cell Biol       Date:  1995-07       Impact factor: 4.304

10.  Measurement of sulfur-containing compounds involved in the metabolism and transport of cysteamine and cystamine. Regional differences in cerebral metabolism.

Authors:  John T Pinto; Tetyana Khomenko; Sandor Szabo; Gordon D McLaren; Travis T Denton; Boris F Krasnikov; Thomas M Jeitner; Arthur J L Cooper
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2009-05-28       Impact factor: 3.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.